DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Hadji P, Kauka A, Ziller M. et al.
Effects of zoledronic acid on bone mineral density in premenopausal women receiving neoadjuvant or adjuvant therapies for HR+ breast cancer: the ProBONE II study.
Osteoporos Int 2014;
25: 1369-1378
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.